Controlled Release Drug Delivery Market To Reach $110.13 Billion By 2030

Controlled Release Drug Delivery Market Growth & Trends

The global controlled release drug delivery market size is expected to reach USD 110.13 billion by 2030, registering a CAGR of 10.6% according to a new report by Grand View Research, Inc. The benefits associated with controlled release drug delivery systems such as increased therapeutic efficacy, fewer side effects, and low treatment cost are the factors driving the growth of the market during the forecast period. These technologies offer various benefits over traditional delivery forms. Reduced dosage and dosage frequency, enhanced patient compliance, less gastrointestinal side effects, uniform drug effect, improved drug efficacy and safety, and reduced fluctuation of plasma drug levels are some of the major advantages offered by controlled release technology.

The presence of multiple in-vivo biological barriers that affect the absorption, bioavailability, and stability of the drug has opened a wide horizon for controlled release drug delivery products. For instance, a controlled release drug delivery system has enabled the delivery of even large and complex molecules such as DNA/RNA, proteins, and polypeptides. Additionally, the rising awareness among healthcare professionals, regarding the advantage of controlled release drug delivery systems over conventional systems is expected to drive the demand for the market in long run.

The rapidly increasing geriatric and pediatric population is one of the major factors impacting the growth of the market. Since a major proportion of prescription non-adherence cases is observed in this age group of the population. Innovations in various drug delivery systems have been providing the geriatric and pediatric populations with easy solutions, which are further propelling the market. Controlled release of drugs allows a reduction in overdose in the elderly population as they can be altered according to the required dosage over a specific period of time.

 Request a free sample copy or view report summary: Controlled Release Drug Delivery Market Report

Controlled Release Drug Delivery Market Report Highlights

• Based on application, oral controlled release systems held the largest share in the market in 2022 owing to increasing usage and ease of convenience offered for the administration of medication

• Targeted drug delivery is poised to be the fastest-growing technology segment during the forecast period owing to its various benefits such as increased therapeutic efficacy coupled with increased safety

• The osmotic delivery segment, based on activation modulation drug delivery systems, is likely to witness the highest CAGR due to its ability to not be affected by various factors, such as pH, food consumption, and gastrointestinal motility

Controlled Release Drug Delivery Market Segmentation

Grand View Research has segmented the global controlled release drug delivery market based on technology, release mechanism, application. and region:

Controlled Release Drug Delivery Technology Outlook (Revenue in USD Million, 2018 - 2030)

• Wurster Technique

• Coacervation

• Micro Encapsulation

• Implants

• Transdermal

• Targeted Delivery

• Others (Microelectromechanical Technology, Liposomes)

Controlled Release Drug Delivery Release Mechanism Outlook (Revenue, USD Million, 2018 - 2030)

• Polymer Based Systems

• Micro Reservoir Partition Controlled Drug Delivery Systems

• Feedback Regulated Drug Delivery Systems

• Activation-modulated Drug Delivery Systems

  • Osmotic Pressure Activated

  • Hydrodynamic Pressure Activated

  • Vapor Pressure Activated

  • Mechanically Activated

  • Magnetically Activated

• Chemically Activated

  • pH Activated

  • Hydrolysis Activated

  • Enzyme Activated

Controlled Release Drug Delivery Application Outlook (Revenue, USD Million; 2018 - 2030)

• Metered Dose Inhalers

• Injectable

• Transdermal and Ocular Patches

• Infusion Pumps

• Oral Controlled-drug delivery Systems

• Drug Eluting Stents

Controlled Release Drug Delivery Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Netherland

  • Switzerland

  • Russia

  • Belgium

  • Sweden

• Asia Pacific

  • China

  • Japan

  • India

  • Thailand

  • South Korea

  • Indonesia

  • Philippines

  • Vietnam

  • Singapore

  • Malaysia

• Latin America

  • Brazil

  • Mexico

  • Argentina

  • Colombia

  • Chile

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

  • Israel

List of Key Players of Controlled Release Drug Delivery Market

• Orbis Biosciences, Inc.

• Merck and Co., Inc.

• Alkermes plc

• Johnson and Johnson

• Coating Place, Inc.

• Corium International, Inc.

• Depomed, Inc.

• Pfizer, Inc

• Aradigm Corporation

• Capsugel.